NCT04801953View on ClinicalTrials.gov

Nimodipine in Vestibular Schwanommas

PHASE2RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 4, 2021

Primary Completion Date

April 9, 2024

Study Completion Date

April 9, 2024

Conditions
Vestibular Schwannoma
Interventions
DRUG

NiMODipine Injectable Solution

nimodipine solution is applied to cranial nerves during resection of vestibular schwannoma

OTHER

Placebo

Sodium chloride solution is applied to cranial nerves during surgery

Trial Locations (1)

1090

RECRUITING

Medical University of Vienna, Vienna

All Listed Sponsors
lead

Medical University of Vienna

OTHER